CDC to meet on boosters just hours after FDA authorized their use in seniors and high-risk individuals, and Africa slams UK’s travel rules

A team of advisers to the Centers for Disease Control and Prevention is expected to wrap up a two-day meeting Thursday on booster shots of the COVID-19 vaccine, just hours after the Food and Drug Administration authorized their use for senior citizens and those at risk of severe disease.